UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expression of fat mobilizing genes in human epicardial adipose tissue

Atherosclerosis, 2012-01, Vol.220 (1), p.122-127

2012

Volltextzugriff (PDF)

Activation of the complement system: a crucial link between inflammation and atherosclerosis?

European journal of clinical investigation, 2004-12, Vol.34 (12), p.800-802

Kostner, K. M.

2004

Volltextzugriff (PDF)

Does lipoprotein(a) predict risk in type 2 diabetes?

European journal of clinical investigation, 2006-02, Vol.36 (2), p.67-68

Kostner, K. M.

2006

Volltextzugriff (PDF)

Urinary excretion of apo(a) fragments. Role in apo(a) catabolism

Arteriosclerosis, thrombosis, and vascular biology, 1996-08, Vol.16 (8), p.905-911

1996

Volltextzugriff (PDF)

Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans

European journal of clinical investigation, 2005-04, Vol.35 (4), p.251-258

2005

Volltextzugriff (PDF)

When should we measure lipoprotein (a)?

European heart journal, 2013-11, Vol.34 (42), p.3268-3276

2013

Volltextzugriff (PDF)

Therapy of hyper-Lp(a)

Handbook of experimental pharmacology, 2005 (170), p.519

2005

Volltextzugriff (PDF)

Plasma delipidation process induces rapid regression of atherosclerosis and mobilisation of adipose tissue

Journal of clinical apheresis, 2005-10, Vol.20 (3), p.143-153

2005

Volltextzugriff (PDF)

Urinary excretion of apo(a) in patients after kidney transplantation

Nephrology, dialysis, transplantation, 1997-12, Vol.12 (12), p.2673-2678

1997

Volltextzugriff (PDF)

LDL-apheresis significantly reduces urinary apo(a) excretion

European journal of clinical investigation, 1997-01, Vol.27 (1), p.93-95

1997

Volltextzugriff (PDF)

Urinary apo(a) discriminates coronary artery disease patients from controls

Atherosclerosis, 1997-02, Vol.129 (1), p.103-110

1997

Volltextzugriff (PDF)

Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function

European journal of clinical investigation, 1998-06, Vol.28 (6), p.447-452

1998

Volltextzugriff (PDF)

CT13PREVENTION OF ATRIAL FIBRILLATION AFTER CABG WITH OMEGA-3 POLYUNSATURATED FATTY ACIDS

ANZ journal of surgery, 2007-05, Vol.77 (s1), p.A10-A10

2007

Volltextzugriff (PDF)

Urinary apolipoprotein (a) excretion in patients with proteinuria

Annals of medicine (Helsinki), 1998, Vol.30 (5), p.497-502

1998

Volltextzugriff (PDF)

Lecithin-cholesterol acyltransferase activity in normocholesterolaemic and hypercholesterolaemic roosters: modulation by lipid apheresis

European journal of clinical investigation, 1997-03, Vol.27 (3), p.212-218

1997

Volltextzugriff (PDF)

Commentary: Activation of the complement system: a crucial link between inflammation and atherosclerosis?

European journal of clinical investigation, 2004-12, Vol.34 (12), p.800

Kostner, K M

2004

Volltextzugriff (PDF)

Lp(a) and coronary disease: rules of engagement - when to measure and how to treat

SAMJ: South African Medical Journal, 2009-07, Vol.99 (7), p.502-504

2009

Volltextzugriff (PDF)

Lp(a) and coronary disease: rules of engagement--when to measure and how to treat

South African medical journal, 2009-07, Vol.99 (7), p.502

2009

Volltextzugriff (PDF)

Lipoprotein(a): still an enigma?

Current opinion in lipidology, 2002-08, Vol.13 (4), p.391-396

2002

Volltextzugriff (PDF)

Lipid apheresis: An in vivo application of plasma delipidation with organic solvents resulting in acute transient reduction of circulating plasma lipids in animals

Journal of clinical apheresis, 1995, Vol.10 (2), p.61-69

1995

Volltextzugriff (PDF)

Lipid apheresis in an animal model causes in vivo changes in lipoprotein electrophoretic patterns

Journal of clinical apheresis, 1996, Vol.11 (2), p.61-70

1996

Volltextzugriff (PDF)

Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease

Clinica chimica acta, 2006-03, Vol.365 (1), p.129-134

2006

Volltextzugriff (PDF)

CT13 PREVENTION OF ATRIAL FIBRILLATION AFTER CABG WITH OMEGA‐3 POLYUNSATURATED FATTY ACIDS

ANZ journal of surgery, 2007-05, Vol.77 (s1), p.A10-A10

2007

Volltextzugriff (PDF)

Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients. Commentary

European journal of clinical investigation, 2006, Vol.36 (2)

2006

Volltextzugriff (PDF)

Effects of simvastatin on blood lipids, vitamin E, coenzyme Q 10 levels and left ventricular function in humans

European journal of clinical investigation, 2005-04, Vol.35 (4), p.251-258

2005

Volltextzugriff (PDF)

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(178)
Mit Volltextzugriff
(159)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expression of fat mobilizing genes in human epicardial adipose tissue

Activation of the complement system: a crucial link between inflammation and atherosclerosis?

Does lipoprotein(a) predict risk in type 2 diabetes?

Urinary excretion of apo(a) fragments. Role in apo(a) catabolism

Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans

When should we measure lipoprotein (a)?

Therapy of hyper-Lp(a)

Plasma delipidation process induces rapid regression of atherosclerosis and mobilisation of adipose tissue

Urinary excretion of apo(a) in patients after kidney transplantation

LDL-apheresis significantly reduces urinary apo(a) excretion

Urinary apo(a) discriminates coronary artery disease patients from controls

Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function

CT13PREVENTION OF ATRIAL FIBRILLATION AFTER CABG WITH OMEGA-3 POLYUNSATURATED FATTY ACIDS

Urinary apolipoprotein (a) excretion in patients with proteinuria

Lecithin-cholesterol acyltransferase activity in normocholesterolaemic and hypercholesterolaemic roosters: modulation by lipid apheresis

Commentary: Activation of the complement system: a crucial link between inflammation and atherosclerosis?

Lp(a) and coronary disease: rules of engagement - when to measure and how to treat

Lp(a) and coronary disease: rules of engagement--when to measure and how to treat

Lipoprotein(a): still an enigma?

Lipid apheresis: An in vivo application of plasma delipidation with organic solvents resulting in acute transient reduction of circulating plasma lipids in animals

Lipid apheresis in an animal model causes in vivo changes in lipoprotein electrophoretic patterns

Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease

CT13 PREVENTION OF ATRIAL FIBRILLATION AFTER CABG WITH OMEGA‐3 POLYUNSATURATED FATTY ACIDS

Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients. Commentary

Effects of simvastatin on blood lipids, vitamin E, coenzyme Q 10 levels and left ventricular function in humans

Suchergebnisse filtern